These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29512550)

  • 1. Botulinum toxin injections for dystonias.
    Sase N; Gnanamuthu C; Prabhakar S
    Neurol India; 1997; 45(3):198. PubMed ID: 29512550
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
    Lu CS; Chen RS; Tsai CH
    J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A; Brannan PA
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.
    Blitzer A; Brin MF; Fahn S; Lange D; Lovelace RE
    Laryngoscope; 1986 Nov; 96(11):1300-1. PubMed ID: 3773633
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection.
    Young DL; Halstead LA
    J Voice; 2014 Nov; 28(6):830-4. PubMed ID: 25008379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin in spasticity treatment].
    Sławek J
    Neurol Neurochir Pol; 1998; 32 Suppl 1():71-84. PubMed ID: 9608556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injection for the treatment of oromandibular dystonia.
    Blitzer A; Brin MF; Greene PE; Fahn S
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):93-7. PubMed ID: 2916831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dystonia: therapeutic aspects].
    Papaterra Limongi JC
    Arq Neuropsiquiatr; 1996 Mar; 54(1):147-55. PubMed ID: 8736161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergence spasm treated with botulinum toxin.
    Kaczmarek BB; Dawson E; Lee JP
    Strabismus; 2009; 17(1):49-51. PubMed ID: 19301195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
    Shaari CM; Sanders I
    Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.